PELD Score (Pediatric End-Stage Liver Disease)
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۶۰ • واحد: mg/dL
حداقل ۰.۸ — حداکثر ۱۵
حداقل ۱ — حداکثر ۶ • واحد: g/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Scored—
The PELD Score (Pediatric End-Stage Liver Disease) calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include bilirubin. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Pediatric End-Stage Liver Disease (PELD) score for children <12 years: 4.80×ln(bilirubin) + 18.57×ln(INR) − 6.87×ln(albumin) + 4.36×(age <1 yr) + 6.67×(growth failure). Values <1 set to 1 before ln. Higher = higher waitlist mortality.
Clinical Indication
The PELD Score (Pediatric End-Stage Liver Disease) is indicated for bedside clinical practice to support Pediatric End-Stage Liver Disease (PELD) score for children <12 years: 4.80×ln(bilirubin) + 18.57×ln(INR) − 6.87×ln(albumin) + 4.36×(age <1 yr) + 6.67×(growth failure). Values <1 set to 1 before ln. Higher = higher waitlist mortality.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.
Limitations & Contraindications
Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.
Clinical Pearls & Action Plan
Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice.
PELD = 4.80·ln(bili) + 18.57·ln(INR) − 6.87·ln(alb) + 4.36·(age<1) + 6.67·(growth failure).
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| bilirubin | float | Yes | Total bilirubin(mg/dL) |
| inr | float | Yes | INR |
| albumin | float | Yes | Albumin(g/dL) |
| age_under_1 | string | Yes | Age under 1 year |
| growth_failure | string | Yes | Growth failure (<-2 SD) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | Scored | PELD score |
Evidence-Based References (EBM)
- Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864-871. (PELD: McDiarmid SV et al., UNOS allocation policy).